Plain-English translation of NCT07582926 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at cortisol—a natural hormone your body makes—in patients who are critically ill with sepsis or septic shock in the intensive care unit. Researchers want to understand whether measuring cortisol levels can help doctors predict which patients are at higher risk and identify those who might need additional support. By tracking cortisol and other blood markers over time, the study aims to improve how doctors assess and care for the sickest patients.
When the body is fighting a severe infection like sepsis, cortisol helps keep blood pressure stable and control inflammation. Some patients don't make enough cortisol during critical illness, which may make their condition worse. This study exists to understand whether checking cortisol levels could help doctors spot high-risk patients earlier and give them better care.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be followed closely during your stay in the intensive care unit. Blood samples would be taken to measure your cortisol levels and other markers of infection and inflammation. Doctors would record information about your condition, vital signs, and how you recover over time. The study tracks outcomes at different time points—while in the ICU, at 28 days, and at 90 days—to see how cortisol levels relate to recovery and survival.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Turkey (Türkiye)